Health Catalyst (HCAT)
(Delayed Data from NSDQ)
$6.48 USD
-0.06 (-0.92%)
Updated May 3, 2024 04:00 PM ET
After-Market: $6.49 +0.01 (0.15%) 7:58 PM ET
2-Buy of 5 2
C Value D Growth C Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
HCAT 6.48 -0.06(-0.92%)
Will HCAT be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for HCAT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HCAT
Premium Growth Propels Humana (HUM) to Easy Q1 Earnings Beat
Elevance (ELV) Q1 Earnings Beat on Rate Hikes, Guidance Raised
HCAT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Acadia Healthcare (ACHC) Opens Facility to Address Mental Health
Brookdale Senior (BKD) Sees Y/Y Increase in Q1 Occupancy Levels
Down -24.71% in 4 Weeks, Here's Why You Should You Buy the Dip in Health Catalyst (HCAT)
Other News for HCAT
Analysts’ Top Healthcare Picks: Health Catalyst (HCAT), Sartorius (GB:0NIQ)
Health Catalyst to Announce First Quarter 2024 Operating Results and Host Conference Call on Thursday, May 9, 2024
HROW, HCAT and EGRX are among after hour movers
R1 RCM, Health Catalyst downgraded as KeyBanc reviews health-tech space
SMART Global Reports Q2 Results, Joins Health Catalyst And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session